Pharmaceutical & Life Sciences

Search Pharmaceutical & Life Sciences stories

Latest Stories

Pfizer Sues Alkem to Block Copies of Inlyta Kidney-Cancer Drug

A copy of Pfizer Inc.‘s kidney-cancer chemotherapy treatment Inlyta proposed by Alkem Laboratories Ltd. infringes a patent for the drug, the pharmaceutical giant said in a new federal lawsuit.

By Christopher Yasiejko

Biogen Acquisition of Apellis Spells End to Derivative Lawsuit

Apellis Pharmaceuticals Inc. shareholders who sued the drugmaker’s leadership for allegedly concealing the safety risks of a blindness-prevention drug are dropping their suit following Biogen Inc.'s $5.6 billion acquisition of the company.

FDA’s Acting Head to Meet Closed-Door With Rare Disease Groups

The FDA is scheduled to have a closed-door roundtable this week with over a dozen groups advocating for rare disease treatments, according to a senior agency official.

Florida Sues OpenAI, Sam Altman Over Chatbot Safety Concerns

The state of Florida sued OpenAI and Chief Executive Officer Sam Altman, accusing the artificial intelligence company of ignoring safety warnings and releasing its ChatGPT product while knowing it was harmful to users.

Keker Van Nest Names Jamie Slaughter to Managing Partner Post

Litigation boutique Keker, Van Nest & Peters appointed Jamie Slaughter as its new managing partner, the firm announced Monday.

TPG Narrows Endo Trust Fight Over $8 Billion Par Pharma Sale

Private equity giant TPG Capital LP escaped some, but not all, claims brought by Endo International Plc’s unsecured creditors for allegedly profiteering from the $8 billion sale of Par Pharmaceutical Holdings Inc.

Eurofins Employee Files Would-be Class Suit Over Smoker Penalty

A federal lawsuit accuses Eurofins NSC US Inc. of mismanaging an employee wellness program that requires tobacco-using workers to pay an additional $240 per year for healthcare coverage.

Summit Falls as Chinese Data on Cancer Drug Fails to Impress

Summit Therapeutics Inc. declined Monday after doctors questioned whether positive survival data from a Chinese trial of the company’s lung cancer drug ivonescimab would translate to the generally older US population.

NFL Benefit Plans Strike Deal Over Cognitive Test Race-Norming

The NFL’s disability and retirement plans pledged to refrain from making race-based adjustments in the cognitive tests used to assess former players’ levels of disability, according to court filings announcing a class-wide settlement.

23andMe Says California Data Breach Suit Violates Bankruptcy Plan

The bankruptcy plan administrator for the company once known as 23andMe urged a court to halt the state of California’s lawsuit over the handling of a 2023 data breach.